皮質類固醇市場規模、佔有率和成長分析：按產品類型、給藥途徑、適應症、銷售管道、分銷管道和地區分類－2026-2033年產業預測

2024 年全球皮質類固醇市值為 62 億美元，預計到 2025 年將成長至 65.3 億美元，到 2033 年將成長至 98.4 億美元，在預測期（2026-2033 年）內複合年成長率為 5.27%。

全球皮質類固醇市場在應對發炎、自體免疫疾病和內分泌失調方面發揮著至關重要的作用，這主要得益於這些藥物在各種醫療環境中緩解症狀的關鍵作用。該市場已從最初以非專利潑尼松為主，發展成為擁有多元化產品組合的市場，其中包括地塞米松、Methylprednisolone和吸入製劑。慢性呼吸系統疾病和癌症治療的激增顯著影響了市場需求，推動了創新和銷售成長。生物相似藥注射劑的興起進一步改善了市場准入，尤其是在對成本敏感的地區。此外，人工智慧 (AI) 的應用正在革新個人化醫療，根據個別患者數據最佳化劑量和治療方案，從而提供更有效、更個人化的皮質類固醇療法，同時刺激整個產業的創新和投資。

全球皮質類固醇市場的成長要素

慢性發炎和自體免疫疾病（包括氣喘和類風濕性關節炎）的日益普遍，推動了皮質類固醇治療的持續需求。這種持續的需求迫使生產商提高產能，並開發能夠提高患者依從性的新配方。隨著醫療專業人員認知到這種持續的治療需求，在各個醫學領域，皮質類固醇的處方量呈上升趨勢，這進一步刺激了市場活動，並支持了老字型大小企業和新參與企業的收入成長。皮質類固醇的多樣化治療用途和已證實的安全性增強了處方醫生的信心，而持續的臨床研究則揭示了其新的用途，延長了產品的生命週期，並促進了市場的穩定。

全球皮質類固醇市場的限制因素

全球皮質類固醇市場面臨監管機構嚴格監管帶來的許多限制。這些監管要求對皮質類固醇產品的安全性、有效性和品質進行全面評估。這需要在產品上市前獲得大量的臨床前和臨床數據，從而延長研發週期並增加研發成本。這些挑戰可能會阻礙中小企業進入市場，並抑制創新配方的推出。此外，合規活動所需的大量資源投入可能會延遲產品上市，降低市場動態，最終影響成長潛力。持續的上市後監測要求也會從長遠來看增加製造商的營運負擔。

全球皮質類固醇市場趨勢

隨著個人化醫療的日益普及，全球皮質類固醇市場正呈現出顯著的趨勢，即加強精準製劑研發力度。製藥公司正持續開發能夠精準靶向特定發炎路徑、從而降低全身暴露並提高療效的皮質類固醇製劑。奈米載體、吸入式乾粉和經皮吸收貼片先進給藥技術，使臨床醫生能夠根據患者的個別情況客製化給藥方案。這一發展趨勢促進了生物技術創新者和傳統製藥企業之間的合作，從而催生出多元化的差異化產品線，旨在滿足氣喘、皮膚病和眼科等領域的全球未滿足醫療需求，推動永續醫療保健解決方案的構建。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球皮質類固醇市場規模：依產品類型分類

• 糖皮質激素
• 鹽皮質激素

全球皮質類固醇市場規模：依給藥途徑分類

• 外用製劑
• 注射藥物
• 口服製劑
• 吸入製劑

全球皮質類固醇市場規模：依適應症分類

• 皮膚過敏
• 風濕病適應症
• 急性呼吸系統疾病
• 胃腸病學
• 內分泌學
• 其他

全球皮質類固醇市場規模：依銷售管道分類

• 線上
• 離線

全球皮質類固醇市場規模：按分銷管道分類

• 直接的
• 間接

全球皮質類固醇市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck & Co
• AstraZeneca
• Novartis
• AbbVie
• Johnson & Johnson
• Bristol-Myers Squibb
• Eli Lilly and Company
• Teva Pharmaceutical Industries
• Viatris
• Sun Pharmaceutical Industries
• Cipla
• Dr. Reddy's Laboratories
• Lupin
• Aurobindo Pharma
• Zydus Lifesciences
• Hikma Pharmaceuticals
• Amneal Pharmaceuticals

結論與建議

Global Corticosteroids Market size was valued at USD 6.2 Billion in 2024 and is poised to grow from USD 6.53 Billion in 2025 to USD 9.84 Billion by 2033, growing at a CAGR of 5.27% during the forecast period (2026-2033).

The global corticosteroids market is pivotal in addressing inflammation, autoimmune disorders, and endocrine conditions, driven by the crucial role these drugs play in symptom relief across various healthcare settings. Transitioning from a focus on generic prednisone, the market now features a diverse product range, including dexamethasone, methylprednisolone, and inhaled formulations. The surge in chronic respiratory diseases and oncology treatments has significantly influenced demand, prompting innovations and increased sales. The rise of biosimilar injectables has further enhanced market accessibility, especially in cost-sensitive regions. Additionally, the integration of artificial intelligence is revolutionizing personalized therapy, optimizing dosage and treatment methods based on individual patient data, ultimately leading to more effective and tailored corticosteroid treatments while fostering innovation and investment throughout the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Corticosteroids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Corticosteroids Market Segments Analysis

Global corticosteroids market is segmented by product type, route of administration, application indication, sales channel, distribution channel and region. Based on product type, the market is segmented into Glucocorticoids and Mineralocorticoids. Based on route of administration, the market is segmented into Topical Formulations, Injectable Formulations, Oral Formulations and Inhaled Formulations. Based on application indication, the market is segmented into Skin Allergies, Rheumatology Indications, Acute Respiratory Diseases, Gastroenterology, Endocrinology and Others. Based on sales channel, the market is segmented into Online and Offline. Based on distribution channel, the market is segmented into Direct and Indirect. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Corticosteroids Market

The increasing prevalence of chronic inflammatory and autoimmune diseases, including asthma and rheumatoid arthritis, drives a consistent demand for corticosteroid treatments. This ongoing demand compels manufacturers to enhance production capabilities and develop new formulations that enhance patient adherence. As healthcare providers recognize this persistent therapeutic need, they are more inclined to prescribe corticosteroids across a variety of medical disciplines, further boosting market activity and supporting revenue growth for both well-established companies and newcomers. The diverse therapeutic applications and proven safety records of corticosteroids give prescribers confidence, while ongoing clinical research continues to uncover new uses, thereby extending the product lifecycle and fostering market stability.

Restraints in the Global Corticosteroids Market

The global corticosteroids market faces significant restrictions due to the stringent regulations imposed by regulatory agencies, which mandate thorough evaluation of safety, efficacy, and quality for corticosteroid products. This necessitates extensive pre-clinical and clinical data prior to market entry, resulting in prolonged timelines and increased development costs. Such challenges can deter smaller companies from venturing into the market, curtailing the introduction of innovative formulations. Furthermore, the heavy resource allocation needed for compliance activities can delay product launches and diminish market dynamism, ultimately impacting growth potential. Ongoing post-marketing surveillance requirements also add to the operational burdens for manufacturers over the long term.

Market Trends of the Global Corticosteroids Market

The Global Corticosteroids market is witnessing a significant trend towards precision formulation expansion, as the focus on personalized medicine intensifies. Pharmaceutical companies are increasingly developing corticosteroid formulations that precisely target specific inflammatory pathways, thereby reducing systemic exposure and enhancing treatment efficacy. Advanced delivery technologies, including nanocarriers, inhalable dry powders, and transdermal patches, are enabling clinicians to customize dosing regimens according to individual patient profiles. This evolution is fostering collaboration between biotech innovators and traditional manufacturers, resulting in a diverse pipeline of differentiated products that aim to meet the unmet needs in areas such as asthma, dermatology, and ocular disorders globally, promoting sustainable healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Corticosteroids Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Glucocorticoids
• Mineralocorticoids

Global Corticosteroids Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Topical Formulations
• Injectable Formulations
• Oral Formulations
• Inhaled Formulations

Global Corticosteroids Market Size by Application Indication & CAGR (2026-2033)

• Market Overview
• Skin Allergies
• Rheumatology Indications
• Acute Respiratory Diseases
• Gastroenterology
• Endocrinology
• Others

Global Corticosteroids Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• Online
• Offline

Global Corticosteroids Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct
• Indirect

Global Corticosteroids Market Size & CAGR (2026-2033)

• North America (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Route of Administration, Application Indication, Sales Channel, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viatris
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurobindo Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amneal Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations